Searched for
SUVEN LIFE SCIENCE
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...- Sunil Singhania’s Abakkus Portfolio: 6 stocks rally up to 75% in CY26; 5 new buys added in Q4Sunil Singhania’s Abakkus Asset Manager portfolio rose 6% to Rs 2,742 crore in March 2026 quarter, with mixed CY26 performance showing stro...
- 16 smallcaps where promoters raised stakes in the March quarter. Do you own any?Promoters increased their stake in 16 smallcap companies during the March quarter of FY26, signaling confidence. Religare Enterprises saw t...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Gainers & Losers: Cochin Shipyard, Suven Life Sciences among 6 top movers on MondayDomestic markets recovered from intraday lows to close marginally higher. Tech Mahindra and Suven Life Sciences surged, while Cochin Shipya...
- Suven Life Sciences approves 1:2 rights issue; fixes record dateThe issue will ensure one rights equity share for every two fully-paid up equity shares held by the eligible shareholders of the company as...
- Suven Life Sciences zooms 15% as firm to consider rights issueThe company informed exchanges that the board of directors will meet on June 24, 2022, to consider raising of funds through the issue of sh...
- Suven Life Sciences rallies 11%. Here's whyShares of Suven Life have soared about 25 per cent in the last one month. In the last one year, the company has delivered over 65 per cent ...
- Suven Life gets patents for anti-neuro degeneration moleculeThe molecules are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's d...
- Buy Suven Life Sciences with a target of Rs 298: Ashwani Gujral"Suven Life Sciences Ltd. is a 'BUY' call with a target of Rs 298 and a stop loss of Rs 282"
- Buy Suven Life Sciences Ltd with a target of Rs 282 : Ashwani Gujral"Suven Life Sciences Ltd is a 'BUY' call with a target of Rs 282 and a stop loss of Rs of 260"
- Buy Suven Life Sciences with a target of Rs 272: Ashwani Gujral'Suven Life Sciences Ltd. is a 'BUY' call with a target of Rs 272 and a stop loss of Rs 256'
- Buy Suven Life Sciences Ltd with a target of Rs 280: Ashwani GujralSuven Life Sciences Ltd is a 'BUY' call with a target of Rs 280 and a stop loss of Rs 262.
- Suven Life Sciences secures 5 patents; stock ralliesSuven Life Sciences surged as much as 6.97% after the co secured five product patents in Israel, Japan, China and New Zealand for NCEs.
- Suven Life Sciences rallies over 2% as it raises Rs 200 crore via QIPAt 09:50 a.m.; Suven Life Sciences was trading 1.8 per cent higher at Rs 223.95. It hit a low of Rs 221.75 and a high of Rs 225.50 in trade...
- Buy Suven Life Sciences with a target of Rs 212: Prakash GabaSuven Life Sciences is a 'BUY' call with a target of Rs 212 and a stop loss of Rs 194.
- Suven Life Sciences Q1 net profit up by 137%Suven Life Sciences Ltd net profit rise by 137% for Q1. Company to go ahead with amalgamation of Suven Nishtaa Pharma Pvt Ltd with Suven Li...
- Heard on the Street: Suven Life Sciences climbs on Patent acquisitionsShares of Suven Life Sciences gained around 5% after the company secured four overseas product patents.
- Suven Life drug candidate clears toxic tests; stock upSuven Life Sciences clinical drug candidate SUVN- 502, meant for treatment of Alzheimer’s disease and Schizophrenia, has successfully compl...
- Suven Life Sciences secures four product patents; stock upShares of Suven Life Sciences gained momentum after the company secured four product patents, two each from New Zealand and Eurasia corresp...
Load More
